Questions and Answers from the F.I.X.;Insulin Aspart vs Insulin Lispro;Phenothiazines and Contrast Media;Meperidine Removal from Formulary;Furosemide and Albumin as an Admixture
Restricted accessResearch articleFirst published online April, 2002
Questions and Answers from the F.I.X.;Insulin Aspart vs Insulin Lispro;Phenothiazines and Contrast Media;Meperidine Removal from Formulary;Furosemide and Albumin as an Admixture
The Formulary Information Exchange (The F.I.X.) is an online drug information service available to subscribers to The Formulary Monograph Service at http://theformulary.com, or you may log on through drugfacts.com. In this column, we present samples of recent dialog on The F.I.X. If you would like more information on The Formulary Monograph Service or The F.I.X., please call 800-322-4349. If you would like to comment on any of the following questions or answers, please e-mail them to Dennis J. Cada at dcada@drugfacts.com.
Get full access to this article
View all access options for this article.
References
1.
SetterS.M., CorbettC.F., CampbellR.K.Insulin aspart: A new rapid-acting insulin analog.Ann Pharmacother.2000; 34(12): 1423–31.
2.
Letter from Novo Nordisk [by Marianne Karaniewsky, RPh]: Comparison of NovoLog and Humalog. November 16, 2001.
3.
Humalog package insert.Indianapolis, IN: Eli Lilly and Company; May 2000.
4.
HedmanC.A., LindstromT., ArnqvistH.J.Direct comparison of insulin lispro and aspart shows small differences in plasma insulin profiles after subcutaneous injection in type I diabetes [letter].Diabetes Care.2001; 24(6): 1120–1.
